Silver Book Fact

The Study of Osteoporotic Fractures, which began over 20 years ago, found that bone mineral density (BMD) of the hip is one of the best predictors of fracture for women, and that weight loss in the elderly and family history of hip fractures are two of the most important risk factors for this condition. Similar studies have now begun to learn about osteoporosis risk factors in men.

Reference

Title
NIH Fact Sheet: Osteoporosis
Authors
National Institutes of Health
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • 30 drugs are currently in development for osteoporosis.  
  • Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to decrease vertebral fractures by up to 50% after 3 years.  
  • Reducing risk of fracture from 8% to 2% reduces the 5-year fracture incidence from approximately 34% to 10%.  
  • An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.  
  • Teriparatide, or human recombinant PTH, has been shown to decrease vertebral fractures by 65% to 69%, and non-vertebral fragility fractures by around 53%.